FDA Structure/Function Claim Proposal Meeting Slated For Aug. 4
This article was originally published in The Tan Sheet
Executive Summary
The definition of "disease" as it pertains to dietary supplement claims will be re-examined at a public meeting in Washington, D.C. Aug. 4, FDA announced in the July 8 Federal Register. The meeting will address three of the more contentious issues raised in comments on the agency's April 29, 1998 proposed rule on structure/function claims (1"The Tan Sheet" May 4, 1998, pp. 1-5).
You may also be interested in...
Dietary Supplement Implied Disease Claims Still Not Suitable - FDA
FDA affirms its position that "structure/function claims should not imply disease treatment or prevention" in the agency's final rule on dietary supplement claims criteria published in the Jan. 6 Federal Register.
Dietary Supplement Implied Disease Claims Still Not Suitable - FDA
FDA affirms its position that "structure/function claims should not imply disease treatment or prevention" in the agency's final rule on dietary supplement claims criteria published in the Jan. 6 Federal Register.
Dietary Supplement Implied Disease Claims Still Not Suitable - FDA
FDA affirms its position that "structure/function claims should not imply disease treatment or prevention" in the agency's final rule on dietary supplement claims criteria published in the Jan. 6 Federal Register.